SCHEMBL5146904

SCHEMBL5146904

SC(Cl)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.50
ANPEP P15144 1/20 0.48
TAAR1 Q96RJ0 4/20 0.46
SLC6A2 P23975 2/20 0.46
SIGMAR1 Q99720 2/20 0.46
MAOA P21397 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
CYP2A6 P11509 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA1 P30542 1/20 0.46
MDM2 Q00987 1/20 0.45
CYP1A2 P05177 1/20 0.44
IDO1 P14902 1/20 0.43
CPA3 P15088 1/20 0.43
FOLH1 Q04609 1/20 0.43
SLC18A2 Q05940 1/20 0.43
CYP2D6 P10635 1/20 0.43
ALPI P09923 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4650877 0.78 EPHX1 (0.55) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL252017 0.78 EPHX1 (0.55) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL8711135 0.78 EPHX1 (0.55) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL12315063 0.77 CYP1A2 (0.43) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
Bromide SCHEMBL1046181 0.76 EPHX1 (0.52) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL66064 0.74 SIGMAR1 (0.58) EPHX1TAAR1SLC6A2SIGMAR1MAOA
SCHEMBL1278885 0.74 EPHX1 (0.50) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL219294 0.74 EPHX1 (0.50) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL564024 0.74 EPHX1 (0.50) EPHX1ANPEPTAAR1SLC6A2SIGMAR1
SCHEMBL4138291 0.74 EPHX1 (0.50) EPHX1ANPEPTAAR1SLC6A2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229750-B2 Silver halide emulsion and silver halide photographic light-sensitive material FUJIFILM CORPORATION (JP) 2007-06-12 US disclosed
US-7199139-B2 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
EP-1354602-B1 MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT SANKYO CO (JP) 2006-10-04 EP disclosed
EP-1695716-A2 Medicinal compositions containing diuretics and insulin sensitizers Sankyo Company, Limited (JP) 2006-08-30 EP disclosed
US-20050288339-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2005-12-29 US disclosed
US-20050048424-A1 Silver halide emulsion and silver halide photographic light-sensitive material FUJI PHOTO FILM CO., LTD. 2005-03-03 US disclosed
US-20040053974-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent SANKYO COMPANY, LIMITED (JP) 2004-03-18 US disclosed
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2004-01-01 US disclosed
EP-1354602-A1 MEDICINAL COMPOSITIONS CONTAINING DIURETIC AND INSULIN RESISTANCE-IMPROVING AGENT Sankyo Company, Limited (JP) 2003-10-22 EP disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed
US-RE30420-E DIURETIC, HYPOTENSIVE BAYER AKTIENGESELLSCHAFT (DE) 1980-10-21 US disclosed
US-4112227-A DIURETIC, SALURETIC, ANTIHYPERTENSIVE, ANTITHROMBOTIC BAYER AKTIENGESELLSCHAFT (DE) 1978-09-05 US disclosed
US-4101557-A DEHYDROHALOGENATION EXXON RESEARCH & ENGINEERING CO. (US) 1978-07-18 US disclosed
US-4056533-A HYPOTENSIVE AGENTS, ANTICOAGULANTS, DIURETICS BAYER AKTIENGESELLSCHAFT (DT) 1977-11-01 US disclosed
US-4056581-A Process for the preparation of phosphorodichloridothiolates ROHM AND HAAS COMPANY (US) 1977-11-01 US disclosed
US-4008226-A ANTIBIOTIC AMERICAN HOME PRODUCTS CORPORATION (US) 1977-02-15 US disclosed
US-4000294-A DIURESIS OR SALURESIS BAYER AKTIENGESELLSCHAFT (DT) 1976-12-28 US disclosed
US-3992404-A DIURETICS, SALURETICS, ANTIHYPERTENSIVE AGENTS, AND ANTITHROMBOTIC AGENTS BAYER AKTIENGESELLSCHAFT (DT) 1976-11-16 US disclosed
US-3962215-A PHOSPHORYLATION, ACYLATION, WATER, ACID CHLORIDE, ALCOHOL AMERICAN HOME PRODUCTS CORPORATION (US) 1976-06-08 US disclosed
US-3952008-A DIURETIC, SALURETIC, HYPOTENSIVE, ANTITHROMBOTIC BAYER AKTIENGESELLSCHAFT (DT) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002512-A1 Alpha-substituted carboxylic acid derivatives SLC5A1, SLC2A1, GPR119 EPHX1 2395/4885ANPEP 3250/4885TAAR1 1266/4885
US-20040053974-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent GPR119, INSR, IRS1 EPHX1 2426/4885ANPEP 1993/4885TAAR1 3666/4885
US-20050288339-A1 Medicinal compositions containing diuretic and insulin resistance-improving agent GPR119, INSR, IRS1 EPHX1 2426/4885ANPEP 1993/4885TAAR1 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.